Abstract
Background Age-related gait speed decline is associated with pathological brain changes. Despite EEG sensitivity for detecting alteration in the brain function, its clinical use to evaluate walking disorders is rare. In this study, we examined the association of subclinical gait speed deterioration in older individuals with changes in the EEG frequency composition as a marker of mild cerebral dysfunction.
Methods We studied the gait speed of 90 physically active, community-dwelling older adults in two different appointments separated by an interval of 6 years. In the last assessment, resting-state EEG was acquired in all participants. After a visual clinical report, the EEG was transformed to the frequency domain, and the energy of each frequency band was compared against normative data.
Results 63 of 90 older individuals had gait speed deterioration, 87% of which also had an abnormal EEG frequency composition. EEG abnormalities were characterised by an increase in delta and theta bands power, higher than that expected for their age. We found some participants with gait speed decline that also had a decrease in alpha band power. EEG sensitivity for classifying participants with a deterioration in gait speed was 0.86, with a likelihood ratio of 2.9.
Conclusions The subclinical gait speed decline found in this cohort was associated with significant changes in resting-state EEG frequency composition. The sensitivity of EEG frequency abnormalities for identifying older individuals with deterioration in gait speed supports its inclusion in the assessment pathway of older individuals at risk of developing gait disorders.
Key Points
- Independent and physically active older individuals had a sub-clinical gait speed deterioration.
- Gait speed decline was associated with abnormalities in the EEG frequency composition not expected for their age.
- EEG frequency changes had a high sensitivity for classifying older adults with gait speed decline.
- Inclusion of quantitative EEG in the assessment pathway of older adults at risk of mobility disorders could serve in the identification of associated mild brain dysfunction and help in decisions related to appropriate clinical management.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by Aston University - Global Challenge Research Fund (ID 28014) granted to V Rodríguez-Rodríguez and D García-Agustin
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of Funding: This work was supported in part by Aston University - Global Challenge Research Fund (ID 28014) granted to V Rodríguez-Rodríguez and D García-Agustin
Data Availability
Data will be available upon request after publication
